Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Cerevel Therapeutics Holdings Inc
delisted

Cerevel Therapeutics Holdings Inc

CERE · NASDAQ
CERE · NASDAQ
44.96
USD0.330.74%

Latest News

    SeekingAlpha

    AbbVie completes acquisition of Cerevel Therapeutics

      SeekingAlpha

      Cerevel Therapeutics ticks higher amid Nasdaq delisting notice for AbbVie deal

        SeekingAlpha

        Cerevel Therapeutics gains as investors appear more confident on FTC approval for AbbVie

          SeekingAlpha

          Cerevel Therapeutics drops amid report on FTC review of AbbVie deal

            SeekingAlpha

            Cerevel Therapeutics gains on report Tempur Sealy will be the subject of FTC meeting

              SeekingAlpha

              Cerevel Therapeutics sinks amid some worry on FTC review of AbbVie deal

              Hold

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              0USD
              44.96USD

              52 Week Range

              19.59USD
              44.99USD

              Market Cap

              8.19BUSD

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US15678U1280

              CUSIP

              -

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              -

              Book Value

              3.10

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -2.73

              Wall Street Target Price

              43.40

              EPS Estimate Current Year

              -2.83

              EPS Estimate Next Year

              -2.92

              EPS Estimate Current Quarter

              -0.61

              EPS Estimate Next Quarter

              -0.62

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              0

              Gross Profit TTM

              0

              EBITDA

              -484,523,008

              Profit Margin

              0.00%

              Return On Assets TTM

              -29.79%

              Return On Equity TTM

              -92.45%

              Revenue Per Share TTM

              0

              Qtly Revenue Growth YOY

              0.00%

              Diluted Eps TTM

              -2.73

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              0

              Price Sales TTM

              0

              Price Book MRQ

              14.5122

              Enterprise Value Revenue

              0

              Enterprise Value EBITDA

              -12

              Peers analysis

              • Alnylam Pharmaceuticals Inc
                ALNYAlnylam Pharmaceuticals Inc

                253.44

                3.74%
              • UCB SA
                UCBJFUCB SA

                194.90

                1.59%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                673.55

                1.29%
              • argenx SE
                ARGNFargenx SE

                697.42

                0.00%
              • Novo Nordisk A/S
                NVONovo Nordisk A/S

                79.36

                -2.02%
              • UCB SA ADR
                UCBJYUCB SA ADR

                99.54

                -1.69%
              • CSL Ltd
                CSLLYCSL Ltd

                78.70

                -1.34%
              • Moderna Inc
                MRNAModerna Inc

                33.50

                -0.95%
              • CSL Limited
                CMXHFCSL Limited

                155.00

                -0.51%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                512.13

                -0.04%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Cerevel Therapeutics Holdings stock price today?

              What is Cerevel Therapeutics Holdings stock ticker?

              Is CERE stock price going up?

              What is the analyst recommendation for CERE?

              What is CERE market cap?

              Does CERE release financial reports?

              When is CERE next earnings date?

              What were CERE Earnings for the last quarter?

              What was CERE Revenue for the last quarter?

              What was CERE Net Income for the last quarter?

              Does CERE pay dividends?

              How many employees does CERE have?

              What is CERE EBITDA?

              How to buy CERE stocks?

              Should I invest in CERE stock?